TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T05544 AS T23961. XX ID T05544 XX DT 23.05.2003 (created); vma. DT 15.01.2016 (updated); mkl. CO Copyright (C), QIAGEN. XX FA NFATc1A-alpha XX SY NF-AT2A-alpha; NF-AT2alpha; NF-ATc1-Aalpha; NFATc1-alpha. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G005372 NFATC1; HGNC: NFATC1. XX CL C0052; REL/NFAT; 6.1.3.0.1.1. XX SZ 716 AA; 77.8 kDa (cDNA) (calc.). XX SQ MPSTSFPVPSKFPLGPAAAVFGRGETLGPAPRAGGTMKSAEEEHYGYASSNVSPALPLPT SQ AHSTLPAPCHNLQTSTPGIIPPADHPSGYGAALDGGPAGYFLSSGHTRPDGAPALESPRI SQ EITSCLGLYHNNNQFFHDVEVEDVLPSSKRSPSTATLSLPSLEAYRDPSCLSPASSLSSR SQ SCNSEASSYESNYSYPYASPQTSPWQSPCVSPKTTDPEEGFPRGLGACTLLGSPRHSPST SQ SPRASVTEESWLGARSSRPASPCNKRKYSLNGRQPPYSPHHSPTPSPHGSPRVSVTDDSW SQ LGNTTQYTSSAIVAAINALTTDSSLDLGDGVPVKSRKTTLEQPPSVALKVEPVGEDLGSP SQ PPPADFAPEDYSSFQHIRKGGFCDQYLAVPQHPYQWAKPKPLSPTSYMSPTLPALDWQLP SQ SHSGPYELRIEVQPKSHHRAHYETEGSRGAVKASAGGHPIVQLHGYLENEPLMLQLFIGT SQ ADDRLLRPHAFYQVHRITGKTVSTTSHEAILSNTKVLEIPLLPENSMRAVIDCAGILKLR SQ NSDIELRKGETDIGRKNTRVRLVFRVHVPQPSGRTLSLQVASNPIECSQRSAQELPLVEK SQ QSTDSYPVVGGKKMVLSGHNFLQDSKVIFVEKAPDGHHVWEMEAKTDRDLCKPNSLVVEI SQ PPFRNQRITSPVHVSFYVCNGKRKRSQYQRFTYLPANGNAIFLTVSREHERVGCFF XX SC Swiss-Prot#O95644-2 XX FT 43 689 PF00478; IMP dehydrogenase / GMP reductase domain. FT 410 592 PS50254; REL_2. FT 428 588 PF00554; Rel homology domain (RHD). FT 595 694 SM00429; iptmega2. FT 596 694 PF01833; IPT/TIG domain. XX IN T10659 Elf-1; Mammalia. XX MX M01718 V$NFAT2_Q5. XX DR TRANSPATH: MO000035653. DR EMBL: U08015; DR UniProtKB: O95644-2; NFAC1_HUMAN. XX RN [1]; RE0016682. RX PUBMED: 9094628. RA Bassuk A. G., Anandappa R. T., Leiden J. M. RT Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. RL J. Virol. 71:3563-3573 (1997). XX //